![]() |
![]() ![]() ![]() ![]() ![]() |
![]() |
![]() |
![]() | ||||||
|
|
| ||||||
Last
Updated Email the Office of Clinical Trials |
|
![]() |
| Sadek
Hilal, M.D., Ph.D. |
MR spectroscopy has widespread clinical research potential at CPMC and several specific projects have already been identified for investigation in such areas as: cardiac metabolism; brain biochemical changes associated with stroke, epilepsy, brain tumors, various degenerative neurological disorders and psychiatric disorders; and responses induced by chemotherapy of brain tumors and embolization therapy of intracranial arteriovenous malformations. The new system's unparalleled investigative potential will be utilized across several CPMC departments and centers.

Left to right: Richard Sano; Ed Wu, Ph.D.; Bill Thomas;
Dorothy Adams, Ph.D.; Philip O. Alderson, M.D.; Stephen Chan, M.D.;
Dikoma Shungu, Ph.D.; Kenneth Hess
Return to Infrastructure Projects
Copyright © 1997-1999 Columbia-Presbyterian Center